ArticleJournal of gastrointestinal oncology2019

Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma.

Irini Youssef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.